Tumor-endogenous PD-1 promotes cell proliferation and predicts poor survival in non-small cell lung cancer
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 11 (1) , 3-13
Abstract
Tumor-endogenous PD-1 promotes cell proliferation and predicts poor survival in non-small cell lung cancer Fanyi Gan, Chuanfen Zhang, Liang Xia, Senyi DengKeywords
This publication has 22 references indexed in Scilit:
- Cancer Immunotherapy2013
- Cancer immunotherapy comes of ageNature, 2011
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and PromotionScience, 2011
- B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 ExpressionClinical Cancer Research, 2004
- Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1Immunity, 2004
- Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockadeProceedings of the National Academy of Sciences, 2002
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasionNature Medicine, 2002
- Developmentally regulated expression of the PD-1 protein on the surface of double-negative(CD4–CD8–) thymocytesInternational Immunology, 1996
- Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytesInternational Immunology, 1996
- Incidence of local recurrence and second primary tumors in resected stage I lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995